There is evidence that other BAs (e.g., UDCA) and BA farnesoid X receptor (FXR) agonists (e.g., obeticholic acid) ameliorate the phenotypes of PBC and PSC [5,15,16]. The gene discussed is NR1H4; the disease is primary biliary cholangitis.